Diabetic neuropathy in older adults

Reviews in Endocrine and Metabolic Disorders

Volumn 6, Issue 2, 2005, Pages 117-127

  Witzke, Kara A ^a   Vinik, Aaron I ^b  

^a NORFOLK STATE UNIVERSITY   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Distal polyneuropathy (DPN); Entrapment syndrome; Large fiber neuropathy; Painful neuropathy; Peripheral neuropathy

Indexed keywords

2 (4 BROMO 2 FLUOROBENZYL)SPIRO[1,2,3,4 TETRAHYDROPYRROLO[1,2 A]PYRAZINE 4,3' PYRROLIDINE] 1,2',3',5' TETRAONE; ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; C PEPTIDE; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPALRESTAT; FIDARESTAT; GABAPENTIN; GAMMA LINOLENIC ACID; INOSITOL; LEVACECARNINE; LIDOCAINE; NERVE GROWTH FACTOR; NORADRENALIN UPTAKE INHIBITOR; OPIATE; PONALRESTAT; PREGABALIN; PROSTAGLANDIN DERIVATIVE; RUBOXISTAURIN; SORBINIL; THIOCTIC ACID; TOLRESTAT; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; ZENARESTAT; ZOPOLRESTAT;

CLINICAL FEATURE; DIABETIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; ELDERLY CARE; ELECTROMYOGRAM; HUMAN; MONONEUROPATHY; MOTOR NEUROPATHY; NERVE COMPRESSION; PATHOGENESIS; POLYNEUROPATHY; REVIEW;

ACTIVITIES OF DAILY LIVING; AGED; AGING; DIABETIC NEUROPATHIES; DIAGNOSIS, DIFFERENTIAL; GAIT DISORDERS, NEUROLOGIC; HUMANS;

EID: 18044382695     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-005-6724-7     Document Type: Review

References (53)

1. Vinik AI, Mitchell BD, Leichter SB, Wagner AL, O'Brian JT, Georges LP. Epidemiology of the complications of diabetes. In: Leslie RDG, Robbins DC, eds. Diabetes: Clinical Science in Practice. Cambridge. United Kingdom: Cambridge University Press, 1995:221-287.
2. Knuiman M, Welborn T, McCann V, Stanton K, Constable I. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-1339.
3. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:1-5.
4. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 1998;20:169-181.
5. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994;331(13):854-860.
6. Menz HB, Lord SR, St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Arch Phys Med Rehabil 2004;85(2):245-252.
7. Maty SC, Fried LP, Volpato S, Williamson J, Brancati FL, Blaum CS. Patterns of disability related to diabetes mellitus in older women. J Gerontol A Biol Sci Med Sci 2004;59(2):148-153.
8. Richardson JK, Thies SB, DeMott TK, Ashton-Miller JA. A comparison of gait characteristics between older women with and without peripheral neuropathy in standard and challenging environments. J Am Getiatr Soc 2004;52(9):1532-1537.
9. Vinik AI, Erbas T. Recognizing and Treating Diabetic Autonomic Neuropathy. Cleveland Clinic Journal of Medicine 2001;68(11):928-944.
10. Vinik A, Mehrabyan A. Diagnosis and Management of Diabetic Autonomic Neuropathy. Comprehensive Therapy 2003;29(2/3):130-145.
11. Brownlee M. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic complications. In: Rifkin H, Porte D, eds. Diabetes Mellitus: Theory and Practice. New York, Amsterdam, London: Elsevier, 1990:279.
12. Vinik A, Mehrabyan A, Colen L, Boulton A. Focal entrapment neuropathies in diabetes. Diabetes Care 2004;27(7):1783-1788.
13. Wilbourn AJ. Diabetic entrapment and compression neuropathies. In: Dyck PJ, Thomas PK, eds. Diabetic Neuropathy. Philadelphia: Saunders, 1999;481-508.
14. Kapritskaya Y, Novak C, Mackinnon S. Prevalence of smoking, obesity, diabetes mellitus and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002;48(3):269-279.
15. Vinik AI, Holland MT, LeBeau JM, Liuzzi FJ, Stansberry KB, Colen LB. Diabetic neuropathies. Diabetes Care 1992;15:1926-1975.
16. Leedman PJ, Davis S, Harrison LS. Diabetic amyotrophy. Reassessment of the clinical spectrum. Aust. N. Z. J. Med 1988;18:768-773.
17. Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland syndrome (Diabetic amyotrophy). Arch Neurol 1991;48:1130-1135.
18. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38(6):869-880.
19. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications ill insulin-dependent diabetes mellitus. New Eng J Med 1993;329:977-986.
20. Vinik AI, Pittenger GL, Milicevic Z, Knezevic-Cuca J. Autoimmune Mechanisms in the Pathogenesis of Diabetic Neuropathy. In: Eisenbarth RG, eds. Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. Georgetown: Landes Company, 1998:217-251.
21. Steck AJ, Kappos L. Gangliosides and autoimmune neuropathies: Classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry 1994;57(Suppl):26-28.
22. Vinik A. Diagnosis and management of diabetic neuropathy. Clinics in Geriatric Medicine 1999;15(2):293-319.
23. Milicevic Z, Pittenger GL, Stansberry KB, Vinik AI. Raised antiganglioside GM1 antibody (GM1 Ab) titers in a subset of patients with distal symmetric polyneuropathy (DSPN). Diabetes 1997;46(Suppl. 1):125A.
24. Sharma K, Cross J, Farronay O, Ayyar D, Sheber R, Bradley W. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002;59:758-765.
25. Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995;52:1053-1061.
26. Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995;18:574-584.
27. Yu RK, Ariga T, Kohriyama T, Kusonoki S, Maeda Y, Myatani N. Autoimmune mechanisms in peripheral neuropathies. Ann Neurol 1990;27(Suppl. 1):S30-S35.
28. Zhuang H-X, Snyder CK, Pu S-F, Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996;140(2):198-205.
29. Said G, Goulon-Goreau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;35(5):559-569.
30. Young MJ, Marshall M, Adams JE, Selby P, Boulton AJM. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-38.
31. Haslbeck KM, Bierhaus A, Erwin S, Kirchner A, Nawroth P, Schlotzer U, Neundorfer B, Hess D. Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve 2004;29(6):853-860.
32. Grant WP, Sullivan R, Sonenshine DE, Adam M, Slusser JH, Carson KA, Vinik AI. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg 1997;36(4):272-278.
33. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 2004;43(5):285-289.
34. Cavanagh PR, Derr JA, Ulbrecht JS, Maser RE, Orchard TJ. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med 1992;9(5):469-474.
35. Nelson ME, Fiatarone MA, Morganti CM, Trice I, Greenberg RA, Evans WJ. Effects of high-intensit strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. JAMA 1994;272:1909-1914.
36. Liu-Ambrose T, Khan KM, Eng JJ, Janssen PA, Lord SR, McKay HA. Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial. J Am Geriatr Soc 2004;52(5):657-665.
37. Murray H, Veves A, Young M, Richie D, Boulton A. Role of experimental socks in the care of the high risk diabetic foot. A multi-center patient evaluation study. American group for the study of experimental hosiery in the diabetic foot. Diabetes Care 1993;16(8):1190-1192.
38. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:252-263.
39. Low P, Dotson R. Symptom treatment of painful neuropathy. JAMA 280,1863-1864:1998.
40. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159(16):1931-1937.
41. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DS, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60(11):1524-1534.
42. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA 2004;291(5):605-614.
43. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001;57(3):505-509.
44. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;59(5 Suppl 2):S14-S17.
45. Raskin P, Donofrio P, Rosenthal N, Hewitt D, Jordan D, Xiang J, Vinik AI. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004;63:865-873.
46. Thomas PK. Classification, differential diagnosis and staging of diabetic peripheral neuropathy. Diabetes 1997;46(Suppl 2):S54-S57.
47. Barney Y, Bossmeyer R, Kokomen E. Neurological manifestations of aging. Am Ger Soc 1990;32:411-419.
48. Maki BE, Holliday PJ, Fernie GR. Aging and postural control. A comparison of spontaneous- and induced-sway balance tests. J Am Geriatr Soc 1990;38(1):1-9.
49. Potvin AR, Syndulko K, Tourtellotte WW, Lemmon JA, Potvin JH. Human neurologic function and the aging process. J Am Geriatr Soc 1980;1:1-9.
50. Boulton AJ, Vinik A, Arezzo J, Bril V, Feldman E, Freeman R, Malik R, Maser R, Sosenko J, Ziegler D. Position statement: Diabetic neuropathies. Diabetes Care. 2004 (Submitted).
51. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973-1988.
52. Vinik AI, Milicevic Z. Recent advances in the diagnosis and treatment of diabetic neuropathy. The Endocrinologist 1996;6:443-461.
53. Vinik A, Mehrabyan A. Diabetic Neuropathies. Medical Clinics of North America 2004;88(4):947-999.